Figure 4From: Intra coronary freshly isolated bone marrow cells transplantation improve cardiac function in patients with ischemic heart diseaseNYHA classification and BNP levels in both groups. There were no significant differences of baseline NYHA classification and BNP levels between two groups. 6 months after cell therapy there were a significant decrease of NYHA classification and BNP levels compared to control group without cell therapy. Moreover, no significant changes were observed in the control group at follow up.Back to article page